PEAK6 Group’s Novartis NVS Stock Holding History

PEAK6 Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$667K	Buy	9,857 +9,655	+4,780%	+$666K	﹤0.01%	2327
2018 Q1	$15K	Buy	+202	New	+$15.4K	﹤0.01%	4148
2017 Q2	–	Sell	-12,804	Closed	-$907K	–	4857
2017 Q1	$852K	Sell	12,804 -43,411	-77%	-$2.89M	0.01%	1816
2016 Q4	$3.67M	Buy	56,215 +40,828	+265%	+$2.65M	0.03%	884
2016 Q3	$1.09M	Buy	+15,387	New	+$1.12M	0.01%	1706
2016 Q2	–	Sell	-27,686	Closed	-$1.91M	–	4621
2016 Q1	$1.8M	Sell	27,686 -19,782	-42%	-$1.35M	0.01%	1231
2015 Q4	$3.66M	Sell	47,468 -12,846	-21%	-$1.02M	0.02%	924
2015 Q3	$4.97M	Buy	60,314 +56,242	+1,381%	+$5.01M	0.03%	896
2015 Q2	$359K	Buy	4,072 +2,524	+163%	+$232K	﹤0.01%	3121
2015 Q1	$137K	Sell	1,548 -3,285	-68%	-$291K	﹤0.01%	3742
2014 Q4	$401K	Buy	4,833 +1,996	+70%	+$165K	﹤0.01%	2754
2014 Q3	$239K	Buy	2,837 +447	+19%	+$36.2K	﹤0.01%	3150
2014 Q2	$194K	Sell	2,390 -292	-11%	-$23K	﹤0.01%	3244
2014 Q1	$204K	Buy	2,682 +1,228	+84%	+$89.5K	﹤0.01%	3414
2013 Q4	$105K	Sell	1,454 -3,463	-70%	-$241K	﹤0.01%	3982
2013 Q3	$169K	Sell	4,917 -4,349	-47%	-$288K	﹤0.01%	3802
2013 Q2	$587	Buy	+9,266	New	+$603K	﹤0.01%	2626

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

PEAK6 Group's NVS Position: Q2 2018 in Review

PEAK6 Group increased its Novartis (NVS) stake by 4,780% in Q2 2018, buying an estimated $666K and bringing the position to 9,857 shares worth $667K. The position accounts for ﹤0.01% of the portfolio, ranked #2327.

PEAK6 Group first reported a position in NVS in Q2 2013 and has held it in 17 quarters since. The position peaked at $4.97M in Q3 2015. 987 funds tracked by Wall St. Rank hold NVS as of Q2 2018.

PEAK6 Group held 9,857 shares of Novartis worth $667K as of Q2 2018.
PEAK6 Group bought 9,655 Novartis shares in Q2 2018, an estimated $666K.
Novartis made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #2327 holding.
PEAK6 Group first reported a position in Novartis in Q2 2013 and has held it in 17 quarters since.
PEAK6 Group's Novartis position peaked at $4.97M in Q3 2015.
987 funds tracked by Wall St. Rank held Novartis as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.